Publications in collaboration with researchers from Azienda Ospedaliero-Universitaria Careggi (13)

2023

  1. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

    Haematologica

  2. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 4, pp. 787-799

2022

  1. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

    Bone Marrow Transplantation, Vol. 57, Núm. 3, pp. 416-422

  2. Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT (Bone Marrow Transplantation, (2022), 57, 3, (416-422), 10.1038/s41409-021-01553-x)

    Bone Marrow Transplantation

  3. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 5, pp. 1106-1114

2020

  1. Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study

    Blood, Vol. 135, Núm. 5, pp. 381-386

  2. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 9, pp. 2145-2154

  3. Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

    Leukemia

  4. Second cancers in MPN: Survival analysis from an international study

    American Journal of Hematology, Vol. 95, Núm. 3, pp. 295-301

2019

  1. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

    Leukemia, Vol. 33, Núm. 8, pp. 1996-2005

2016

  1. Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study)

    Haemophilia, Vol. 22, Núm. 1, pp. 96-102

2005

  1. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 12, pp. 2619-2626

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886